Stock listing
BNTC Stock Price, News, Filings & Events — Benitec Biopharma Inc.
Selected listing: BNTC · NASDAQ · USD · US
This page tracks Benitec Biopharma Inc.'s BNTC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BNTC:NASDAQ. BNTC:NASDAQ is the stock-level entry point for investors researching Benitec Biopharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Benitec Biopharma Inc. is a public company traded under the ticker BNTC in the American market. The company has a market capitalization of approximately $394 million. Benitec focuses on developing innovative therapeutic solutions in the biotechnology sector.
- Ticker
- BNTC:NASDAQ
- Asset type
- Stock
- Market cap
- $428.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Benitec Biopharma Inc. BNTC:NASDAQ stock context
This page tracks Benitec Biopharma Inc.'s BNTC:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following BNTC:NASDAQ. BNTC:NASDAQ is the stock-level entry point for investors researching Benitec Biopharma Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Benitec Biopharma Inc. is a public company traded under the ticker BNTC in the American market. The company has a market capitalization of approximately $394 million. Benitec focuses on developing innovative therapeutic solutions in the biotechnology sector.
Latest news from Benitec Biopharma Inc.
Benitec Biopharma Releases Full Year 2026 Financial Results and Provides Operational Update
September 14, 2026
Unleash Your Ultimate Kaiju! Godziburst and Godzilla Scramble Figures Available for Pre-Order Starting June 25
June 25, 2026
Benitec Biopharma Releases Third Quarter 2026 Financial Results and Provides Operational Update
May 14, 2026
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting
April 28, 2026
Benitec Biopharma to Host Industry Forum Breakfast Event at the 2026 Muscular Dystrophy Association Clinical and Scientific Conference on March 10, 2026, Highlighting Continued Progress for BB-301, the Only Clinical-Stage Therapeutic in Development fo...
March 10, 2026
Research Benitec Biopharma Inc.
Benitec Biopharma Inc. investor report
Review AI stock analysis and investor report context for BNTC:NASDAQ.
Benitec Biopharma Inc. company profile
View the public company page for Benitec Biopharma Inc. on 6ix.
Benitec Biopharma Inc. news
Read company news and market updates connected to Benitec Biopharma Inc..
Benitec Biopharma Inc. investor events
Find investor webinars, events, and replay context for Benitec Biopharma Inc..